Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System
Overview
Authors
Affiliations
Objectives: The effectiveness of stool-based colorectal cancer (CRC) screening is contingent on colonoscopy completion in patients with an abnormal fecal immunochemical test (FIT). Understanding system and patient factors affecting follow-up of abnormal screening tests is essential to optimize care for high-risk cohorts.
Methods: This retrospective cohort study was conducted in an integrated safety-net system comprised of 11 primary-care clinics and one Gastroenterology referral unit and included patients 50-75 years, with a positive FIT between April 2012 and February 2015.
Results: Of the 2,238 patients identified, 1,245 (55.6%) completed their colonoscopy within 1-year of the positive FIT. The median time from positive FIT to colonoscopy was 184 days (interquartile range 140-232). Of the 13% of FIT positive patients not referred to gastroenterology, 49% lacked documentation addressing their abnormal result or counseling on the increased risk of CRC. Of the patients referred but who missed their appointments, 62% lacked documentation following up on the abnormal result in the absence of a completed colonoscopy. FIT positive patients never referred to gastroenterology or who missed their appointment after referrals were more likely to have comorbid conditions and documented illicit substance use compared with patients who completed a colonoscopy.
Conclusions: Despite access to colonoscopy and a shared electronic health record system, colonoscopy completion after an abnormal FIT is inadequate within this safety-net system. Inadequate follow-up is in part explained by inappropriate screening, but there is an absence of clear documentation and systematic workflow within both primary care and GI specialty care addressing abnormal FIT results.
The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection.
Schafer H, Lajmi N, Valente P, Pedrioli A, Cigoianu D, Hoehne B Diagnostics (Basel). 2025; 15(5).
PMID: 40075895 PMC: 11899545. DOI: 10.3390/diagnostics15050648.
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.
Alagoz O, May F, Doubeni C, Fendrick A, Vahdat V, Estes C J Natl Cancer Inst. 2024; 116(11):1807-1816.
PMID: 39044335 PMC: 11542987. DOI: 10.1093/jnci/djae140.
Lack of Adherence to Guidelines on Follow-Up Colonoscopy after an Abnormal Stool Occult Blood Test.
Malani K, Elfanagely Y, Promrat K J Gastrointest Cancer. 2024; 55(3):1456-1459.
PMID: 38764006 DOI: 10.1007/s12029-024-01039-1.
Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer.
Ciemins E, Mohl J, Moreno C, Colangelo F, Smith R, Barton M JAMA Netw Open. 2024; 7(3):e242693.
PMID: 38526494 PMC: 10964113. DOI: 10.1001/jamanetworkopen.2024.2693.
Screening for Colorectal Cancer: The Role of Clinical Laboratories.
Toth 3rd J, Trivedi M, Gupta S Clin Chem. 2024; 70(1):150-164.
PMID: 38175599 PMC: 10952004. DOI: 10.1093/clinchem/hvad198.